PharmEasy Secures New Debt to Settle Goldman Sachs Loan Amidst Steep Valuation Drop
PharmEasy raises Rs 1,700 crore in debt funding, continuing reliance on high-cost borrowing amid losses.
Read moreDetailsADVERTISEMENT
Tag: PharmEasy
PharmEasy Achieves ₹5,872 Crore Revenue in FY25 with Steady Burn Rates
API Holdings’ PharmEasy reported flat revenue but cut losses by 38%, improving finance and depreciation costs.
Read moreDetails
Leadership Transition at PharmEasy: Siddharth Shah Resigns, Rahul Guha to Assume Role as CEO
Siddharth Shah is stepping down as CEO of API Holdings, transitioning to Vice Chairman on Aug 27, 2025.
Read moreDetails
PharmEasy Founders Unveil All Home, Securing Funding with a $120 Million Valuation
All Home aims to streamline home interiors with a one-stop solution for various design products.
Read moreDetails